Recent News

• 05.28.2025 - BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
• 05.27.2025 - BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
• 05.21.2025 - Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
• 05.13.2025 - BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
• 05.13.2025 - BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
• 05.12.2025 - BD to Announce Financial Results for its Third Quarter of Fiscal 2025
• 05.01.2025 - BD Reports Second Quarter Fiscal 2025 Financial Results
• 04.30.2025 - BD to Present at Bank of America Securities Health Care Conference
• 04.29.2025 - BD Board Declares Dividend
• 04.23.2025 - BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair

Recent Filings

• 05.28.2025 - SD Specialized disclosure report
• 05.27.2025 - 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
• 05.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.02.2025 - 8-K Current report
• 05.01.2025 - EX-99.1 EX-99.1
• 05.01.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.01.2025 - 8-K Current report